Procter & Gamble (NYSE:PG) PT Raised to $170.00 at Barclays

Procter & Gamble (NYSE:PGGet Free Report) had its price target increased by stock analysts at Barclays from $168.00 to $170.00 in a report released on Tuesday, Benzinga reports. The brokerage currently has an “overweight” rating on the stock. Barclays‘s price objective suggests a potential upside of 4.56% from the stock’s previous close.

Other research analysts have also recently issued research reports about the company. The Goldman Sachs Group started coverage on Procter & Gamble in a research report on Friday, March 1st. They issued a “neutral” rating and a $168.00 price objective for the company. Truist Financial raised shares of Procter & Gamble from a “hold” rating to a “buy” rating and boosted their price objective for the stock from $160.00 to $175.00 in a report on Monday, March 11th. UBS Group increased their target price on shares of Procter & Gamble from $172.00 to $178.00 and gave the company a “buy” rating in a report on Wednesday, January 24th. Jefferies Financial Group boosted their price target on Procter & Gamble from $175.00 to $182.00 and gave the stock a “buy” rating in a research note on Monday. Finally, Stifel Nicolaus upped their price target on Procter & Gamble from $155.00 to $157.00 and gave the stock a “hold” rating in a report on Wednesday, January 24th. Seven investment analysts have rated the stock with a hold rating and eleven have issued a buy rating to the stock. According to data from MarketBeat, Procter & Gamble has a consensus rating of “Moderate Buy” and an average price target of $168.81.

Check Out Our Latest Report on PG

Procter & Gamble Stock Up 0.7 %

Shares of NYSE:PG opened at $162.58 on Tuesday. The company has a current ratio of 0.69, a quick ratio of 0.48 and a debt-to-equity ratio of 0.49. The firm has a 50 day simple moving average of $159.46 and a 200-day simple moving average of $153.32. The company has a market capitalization of $383.71 billion, a PE ratio of 26.57, a P/E/G ratio of 3.23 and a beta of 0.44. Procter & Gamble has a twelve month low of $141.45 and a twelve month high of $163.14.

Procter & Gamble (NYSE:PGGet Free Report) last announced its earnings results on Friday, April 19th. The company reported $1.52 EPS for the quarter, beating analysts’ consensus estimates of $1.42 by $0.10. The business had revenue of $20.20 billion during the quarter, compared to analysts’ expectations of $20.43 billion. Procter & Gamble had a net margin of 18.00% and a return on equity of 33.91%. The business’s revenue was up .6% compared to the same quarter last year. During the same period in the prior year, the company earned $1.37 earnings per share. On average, equities analysts predict that Procter & Gamble will post 6.54 EPS for the current fiscal year.

Insider Buying and Selling at Procter & Gamble

In related news, CEO Ma. Fatima Francisco sold 45,000 shares of the company’s stock in a transaction on Monday, January 29th. The stock was sold at an average price of $156.00, for a total value of $7,020,000.00. Following the completion of the transaction, the chief executive officer now directly owns 973 shares in the company, valued at $151,788. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In related news, CEO Ma. Fatima Francisco sold 45,000 shares of the business’s stock in a transaction that occurred on Monday, January 29th. The shares were sold at an average price of $156.00, for a total value of $7,020,000.00. Following the completion of the sale, the chief executive officer now directly owns 973 shares in the company, valued at $151,788. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CEO Gary A. Coombe sold 22,000 shares of the stock in a transaction that occurred on Friday, February 23rd. The stock was sold at an average price of $161.32, for a total transaction of $3,549,040.00. Following the transaction, the chief executive officer now directly owns 36,845 shares in the company, valued at approximately $5,943,835.40. The disclosure for this sale can be found here. In the last three months, insiders sold 100,865 shares of company stock worth $16,029,280. Insiders own 0.17% of the company’s stock.

Hedge Funds Weigh In On Procter & Gamble

A number of large investors have recently modified their holdings of the company. Advantage Trust Co acquired a new position in Procter & Gamble during the fourth quarter valued at approximately $28,000. Wyrmwood Management LLC acquired a new position in shares of Procter & Gamble during the 4th quarter valued at $29,000. Naples Money Management LLC acquired a new stake in Procter & Gamble in the 4th quarter valued at $29,000. Transcendent Capital Group LLC purchased a new position in Procter & Gamble in the fourth quarter valued at about $31,000. Finally, Criterion Capital Advisors LLC acquired a new position in shares of Procter & Gamble during the fourth quarter worth about $33,000. 65.77% of the stock is currently owned by hedge funds and other institutional investors.

About Procter & Gamble

(Get Free Report)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.

Featured Articles

Analyst Recommendations for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.